ARA290 (Cibinetide)

TL;DR

ARA290, also known as Cibinetide, is a peptide derived from erythropoietin. Research indicates its primary applications may include modulation of inflammatory responses and potential neuroprotective properties.

Key Research Benefits

Studies suggest the following potential effects of ARA290:

• Regulation of chronic inflammatory responses.
• Promotion of tissue protection and healing.
• Possible neuroprotective activity, especially in neurological conditions.
• Research has indicated improved cellular survival in specific conditions.

Mechanism of Action (Simplified)

ARA290 interacts with the innate repair receptor (IRR), a complex derived from erythropoietin receptors. Unlike erythropoietin, ARA290 selectively activates IRR without influencing erythropoiesis. This mechanism contributes to its anti-inflammatory and tissue-repair facilitation properties.

Technical & Storage Specifications

Below are the technical details and storage requirements for ARA290:

| Specification | Detail | |—————–|————————-| | Purity | >99% | | Appearance | White powder | | Solubility | Soluble in water | | Storage | -20°C (long-term) |

Frequently Asked Questions (FAQs)

1. What is the difference between P21 and P021?
P21 and P021 refer to distinct peptides, each with unique molecular structures and applications. ARA290 focuses on anti-inflammatory and neuroprotective potential, while research into P21 emphasizes neurogenesis and memory support.

2. How should it be stored after reconstitution?
After reconstitution, ARA290 should be stored at 4°C and used within a week to maintain stability. For longer storage, aliquot and freeze at -20°C to avoid repetitive freeze-thaw cycles.

3. Is third-party testing (CoA) available?
Yes, all batches of ARA290 are subject to rigorous third-party testing, ensuring purity and quality. Certificates of Analysis (CoA) are available upon request.